Vertex Pharmaceuticals Inc. shares rallied in the extended session Wednesday after the drugmaker topped Wall Street estimates for the quarter. Vertex shares surged 5.5% to $176.02 after hours. The company reported fourth-quarter net income of $100.7 million, or 39 cents a share, compared with $32.9 million, or 13 cents a share, in the year-ago period. Adjusted earnings were 61 cents a share. Revenue rose to $651.6 million from $458.7 million in the year-ago period. Analysts surveyed by FactSet had estimated 53 cents a share on revenue of $592.8 million.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News